Shares of Chemours Co (NYSE: CC) recently traded at $38.91, surpassing the average analyst 12-month target price of $37.33. This shift prompts potential analyst reactions; they may either downgrade the stock’s valuation or adjust their target prices higher depending on the underlying business fundamentals.
Currently, six analysts provide coverage on Chemours Co, with target prices ranging from $30.00 to $45.00, leading to a standard deviation of $5.92. Recent ratings show two “Strong Buy,” one “Buy,” four “Hold,” and no “Sell” or “Strong Sell” ratings, resulting in an average rating of 2.29, where 1 represents a “Strong Buy” and 5 represents a “Strong Sell.”
